Keros Therapeutics Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Keros Therapeutics stock has a consensus rating of "Buy" and an average price target of $21.83. The average 1-year stock price forecast is 109.70% higher than the current stock price, while the lowest is $16 (+53.70%) and the highest is $30 (+188.18%).

Price Target: $21.83 (+109.70%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$16	$21.83	$20	$30
Change	+53.70%	+109.70%	+92.12%	+188.18%

Analyst Ratings

The average analyst rating for Keros Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	May '26	Jun '26
Strong Buy	6	6	5	5	3	3
Buy	0	0	0	0	0	0
Hold	4	4	4	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	9	9	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Zemansky Bank of America Securities	Bank of America Securities	Hold Reiterates $20	Hold	Reiterates	$20	+92.12%	Jun 3, 2026
Yun Zhong Wedbush	Wedbush	Hold Maintains $16	Hold	Maintains	$16	+53.70%	May 19, 2026
Srikripa Devarakonda Truist Financial	Truist Financial	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 15, 2026
Nicholas Lorusso TD Cowen	TD Cowen	Hold Maintains n/a	Hold	Maintains	n/a	n/a	May 15, 2026
Benjamin Burnett Wells Fargo	Wells Fargo	Buy Maintains $20	Buy	Maintains	$20	+92.12%	May 15, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

4.25M

from 244.06M

-98.26%

from 244.06M

Revenue Next Year

18.91M

from 4.25M

344.71%

from 4.25M

EPS This Year

-5.19

from 2.30

EPS Next Year

-5.59

from -5.19

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	20.10M	-	151.00K	3.55M	244.06M	4.25M
Revenue Growth	-	-	-	2,250.99%	6,774.96%	-98.26%
Gross Profit	-35.04M	-87.27M	-135.11M	-170.08M	116.92M	4.25M
Gross Margin	-174.34%	-	-89,474.83%	-4,790.96%	47.91%	100.00%
Operating Income	-56.37M	-114.79M	-169.94M	-210.83M	70.57M	-129.59M
Net Income	-58.74M	-104.68M	-152.99M	-187.35M	87.01M	-120.45M
EPS	-	-	-	-	2.30	-5.19
Free Cash Flow	-39.48M	-33.84M	-81.25M	-108.31M	66.24M	-93.93M
No. Analysts	-	-	-	-	-	8

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	10.0M
Avg	4.3M
Low	n/a

Revenue Growth

Revenue Growth	2026	2027	2028
High	-95.9%
Avg	-98.3%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-4.83
Avg	-5.19
Low	-5.96

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-